Alimera again seeks FDA approval of diabetic eye drug Iluvien
03:36 EDT 2 Aug 2012 | SmartBrief
Alimera Sciences resubmitted Iluvien, a treatment for diabetic macular edema, for FDA approval. -More-
Original Article: Alimera again seeks FDA approval of diabetic eye drug Iluvien
More From BioPortfolio on "Alimera again seeks FDA approval of diabetic eye drug Iluvien"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
